University Of Vermont Medical Center

This study is testing if the blood-thinning medication apixaban can safely prevent dangerous blood clots in people newly diagnosed with aggressive brain tumors (grade 4 glioma). It will involve about 40 adult patients who are starting radiation and chemotherapy. The main goal is …

This study is testing a more precise type of radiation therapy called HART for people with cancer that has spread. The main goal is to see if HART causes fewer stomach and digestive side effects compared to standard radiation. Researchers will measure side effects and quality of …

This study is testing whether a more organized, team-based approach to care helps patients with newly diagnosed brain metastases feel better and understand their prognosis more clearly. It will compare this intensive care model to standard care, focusing on patient-reported sympt…

This study is testing whether a medication called pyridostigmine can safely and effectively treat chronic constipation in people with Parkinson's disease. Sixteen participants with Parkinson's and significant constipation will take the medication for several weeks while tracking …

This study is testing whether remote nutrition coaching helps cancer patients stick to their treatment plans and feel better. Researchers are comparing two approaches: basic written materials versus ongoing monthly coaching sessions. The goal is to see if more support leads to fe…